deh113
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Sep 30, 2024 (NCT06555549)
Timeline
2020s
- Jan 1, 2025
Earliest Phase 3 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Serine/threonine-protein kinase AKTINHIBITOR
AKT1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06268054 | Phase 3 | Feb 28, 2025 | EMS S/A |
| NCT06555549 | N/A | Sep 30, 2024 | EMS S/A |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| EMS S/A | For profit | 2 | 2 | 2 | 2024 |
1 organizations
Page 1 / 1